WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)

Saved in:

Bibliographic Details
Main Authors:	Lisa Kivman, Tabea Kraft, Julia Rauser, Rainer Boxhammer, Stefan Hartle, Brian Schwartz, Paul Manser, Leslie Chinn, Uptal Patel, Donna Flesher, Krzysztof Kiryluk, Jonathan Barratt
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023763
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet